Tools
Tools
Harrison, SL, Buckley, BJR, Miguel Rivera-Caravaca, J, Zhang, J and Lip, GYH (2021) Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. European Heart Journal Quality of Care & Clinical Outcomes, 7 (4). pp. 330-339. ISSN 2058-5225
|
Text
Cardiovascular risk factors, cardiovascular disease, and COVID-19 an umbrella review of systematic reviews.pdf - Published Version Available under License Creative Commons Attribution. Download (445kB) | Preview |
Abstract
Aims: To consolidate evidence to determine (i) the association between cardiovascular risk factors and health outcomes with coronavirus 2019 (COVID-19); and (ii) the impact of COVID-19 on cardiovascular health.
Methods and results: An umbrella review of systematic reviews was conducted. Fourteen medical databases and pre-print servers were searched from 1 January 2020 to 5 November 2020. The review focused on reviews rated as moderate or high-quality using the AMSTAR 2 tool. Eighty-four reviews were identified; 31 reviews were assessed as moderate quality and one was high-quality. The following risk factors were associated with higher mortality and severe COVID-19: renal disease [odds ratio (OR) (95% confidence interval) for mortality 3.07 (2.43–3.88)], diabetes mellitus [OR 2.09 (1.80–2.42)], hypertension [OR 2.50 (2.02–3.11)], smoking history [risk ratio (RR) 1.26 (1.20–1.32)], cerebrovascular disease [RR 2.75 (1.54–4.89)], and cardiovascular disease [OR 2.65 (1.86–3.78)]. Liver disease was associated with higher odds of mortality [OR 2.81 (1.31–6.01)], but not severe COVID-19. Current smoking was associated with a higher risk of severe COVID-19 [RR 1.80 (1.14–2.85)], but not mortality. Obesity associated with higher odds of mortality [OR 2.18 (1.10–4.34)], but there was an absence of evidence for severe COVID-19. In patients hospitalized with COVID-19, the following incident cardiovascular complications were identified: acute heart failure (2%), myocardial infarction (4%), deep vein thrombosis (7%), myocardial injury (10%), angina (10%), arrhythmias (18%), pulmonary embolism (19%), and venous thromboembolism (25%).
Conclusion: Many of the risk factors identified as associated with adverse outcomes with COVID-19 are potentially modifiable. Primary and secondary prevention strategies that target cardiovascular risk factors may improve outcomes for people following COVID-19.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Cardiovascular System & Cardiology; COVID-19 Cardiovascular disease; Cardiovascular risk; Umbrella review; INJURY; DEATH |
| Subjects: | R Medicine > RC Internal medicine > RC1200 Sports Medicine |
| Divisions: | Sport & Exercise Sciences |
| Publisher: | Oxford University Press (OUP) |
| Related URLs: | |
| Date Deposited: | 06 Apr 2022 10:41 |
| Last Modified: | 06 Apr 2022 10:45 |
| DOI or ID number: | 10.1093/ehjqcco/qcab029 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/16600 |
 |
View Item |